Synonyms: S-033188 | S033188 | Xofluza®
baloxavir marboxil is an approved drug (Japan & FDA (2018), EMA (2021))
Compound class:
Synthetic organic
Comment: Baloxavir marboxil is an orally delivered anti-influenza virus drug. It is a prodrug that is converted to baloxavir [1]. Mechanistically baloxavir is a first-in-class inhibitor of the cap-endonuclease (CEN) activity of an acidic protein within the viral polymerase complex [3] that is essential for viral gene transcription and replication. Alternative influenza antivirals (e.g. oseltamivir, peramivir and zanamivir) target the neuraminidase enzyme that is required for fusion and entry of virus into the host cells, and the budding process that releases newly synthesised virions.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes (Japan & FDA (2018), EMA (2021)) |
International Nonproprietary Names ![]() |
|
INN number | INN |
10491 | baloxavir marboxil |
Synonyms ![]() |
S-033188 | S033188 | Xofluza® |
Database Links ![]() |
|
CAS Registry No. | 1985606-14-1 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL4297503 |
DrugBank Ligand | DB13997 |
GtoPdb PubChem SID | 458923783 |
PubChem CID | 124081896 |
Search Google for chemical match using the InChIKey | RZVPBGBYGMDSBG-GGAORHGYSA-N |
Search Google for chemicals with the same backbone | RZVPBGBYGMDSBG |
Search PubMed clinical trials | baloxavir marboxil |
Search PubMed titles | baloxavir marboxil |
Search PubMed titles/abstracts | baloxavir marboxil |
UniChem Compound Search for chemical match using the InChIKey | RZVPBGBYGMDSBG-GGAORHGYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | RZVPBGBYGMDSBG-GGAORHGYSA-N |